Enter keywords
ActivityTopicFaculty ChairLaunch DateCreditExpiration Date
HDLCETP.jpg
CETP as a Therapeutic TargetCardiologyPhilip Barter, MD, PhD11-Oct-121.5 AMA
1.5 ACPE
1.5 ANCC
11-Oct-13257839
advancing_hdl_science_2.png
Cholesterol Efflux and Atheroprotective Effects Video Interview ActivityCardiologyH. Bryan Brewer, Jr., MD, FNLA04-Oct-121.75 AMA
04-Oct-13255245
advancing_hdl_science.png
Cholesterol Efflux Self-Study Slide LibraryCardiologyRobert S. Rosenson, MD, FACC, FAHA, FACP, FNLA26-Sep-122 AMA
26-Sep-13249277
icon_.png
CLM-SAP 16: Hypertriglyceridemia - Diagnosis, Pathophysiology, Clinical Significance and TreatmentCardiology01-Oct-143 AMA
3 ACPE
3 ANCC
3 CDR
30-Sep-17402158
icon_.png
CLM-SAP 17: Guidelines in Clinical Lipidology: Concepts and ControversiesCardiology03-Feb-154 AMA
4 ACPE
4 ANCC
4 CDR
02-Feb-18402190
icon_.png
CLM SAP Edition 14 Evaluation and Management of Familial HypercholesterolemiaCardiologySee Faculty section below for a complete list of faculty.15-Jul-123 AMA
3 ACPE
3 ANCC
3 CDR
14-Jul-14241530
icon_.png
CLM SAP Edition 15 Translation of HDL Science, Part I: Function and MetabolismCardiologySee Faculty section below for a complete list of faculty.28-May-123 AMA
3 ACPE
3 ANCC
3 CDR
27-May-14236239
icon_.png
Controversial Issues and Challenging Cases in HypertriglyceridemiaCardiologyPeter P. Toth, MD, PhD, FCCP, FAHA, FACC20-Aug-131 AMA
1 ACPE
1 ANCC
1 CDR
19-Aug-14315125
icon_.png
Current Therapies to Target HDL - Update on Clinical TrialsCardiologyBenjamin J. Ansell, MD, FNLA*28-May-131 AMA
1 ACPE
1 ANCC
1 CDR
27-May-14294041
icon_.png
Epidemiology and NomenclatureCardiologyPeter P. Toth, MD, PhD, FNLA*25-Jan-131 AMA
1 ACPE
1 ANCC
1 CDR
25-Jan-14268346
icon_.png
Fellows National Lipid Association Self-Assessment Program (NLA-SAP)Cardiology01-Sep-1331-Aug-16337353
icon_.png
HDL Functionality (Non-Efflux Functions) and Relationships to AtherosclerosisCardiologyM. John Chapman, BSc, PhD, DSc19-Dec-121 AMA
1 ACPE
1 ANCC
1 CDR
19-Dec-13267858
advancing_hdl_science.png
HDL Functionality Self-Study Slide LibraryCardiologyRobert S. Rosenson, MD, FACC, FAHA, FACP, FNLA28-Sep-122 AMA
28-Sep-13249407
advancing_hdl_science.png
HDL Functionality Video InterviewCardiologyH. Bryan Brewer, Jr., MD, FNLA26-Sep-122 AMA
26-Sep-13249355
icon_.png
HDL Metabolism, Cholesterol Efflux and Relationship to AtherosclerosisCardiologyH. Bryan Brewer, Jr., MD, FNLA14-Feb-131 AMA
1 ACPE
1 ANCC
1 CDR
14-Feb-14268302
advancing_hdl_science.png
HDL Nomenclature Self-Study Slide Library ActivityCardiologyRobert S. Rosenson, MD, FACC, FAHA, FACP, FNLA10-Sep-121.25 AMA
10-Sep-13244579
icon-howard.gif
Howard
Howard Visit 1 - A 45-year-old male with hypercholesterolemia, psoriasis, and a family history of cardiac diseaseCardiologyMichael H. Davidson, MD, FACC, FACP28-Mar-090.5 AMA
31-Mar-10howard
Howard Visit 2: A 45-year-old male with hypercholesterolemia, psoriasis, and a family history of cardiac diseaseCardiologyTara Lynn Dall, MD25-Feb-100.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
09-Mar-11howard
joseph.gif
Joseph
Joseph Visit 1: A 52-year-old African-American male presenting with erectile dysfunctionCardiologyPeter H. Jones, MD25-Feb-100.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
09-Mar-11joseph
Joseph Visit 2: A 52-year-old African-American male with hypertension and erectile dysfunctionCardiologyPeter H. Jones, MD, FNLA04-May-100.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
03-May-11joseph
icon_june.gif
June Visits 1 - 2: Severe Hypertriglyceridemia in a 6 Month Old ChildPediatrics​Don P. Wilson, MD, FNLA24-Jul-1423-Jul-15june
icon_.png
Lipid Competency AssessmentCardiology01-Oct-1430-Sep-17406242
icon-margy.gif
Margy
Margy Visit 1 - 47-Year-Old Woman with Severe Hypertriglyceridemia and Type II DiabetesCardiologyTara Lynn Dall, MD19-Aug-090.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
31-Aug-10margy
Margy Visit 2 - 47-Year-Old Woman with Severe Hypertriglyceridemia and Type II DiabetesCardiologyTara Lynn Dall, MD12-Oct-090.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
11-Oct-10margy
icon_mellissa.gif
Mellissa
Mellissa Visit 1: Patient-centric Approaches to Dyslipidemia: Risk Recognition and Management of Low HDL-CCardiologyJames A. Underberg, MD, MS, FACPM, FACP, FNLA08-Mar-110.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
08-Mar-12mellissa
icon_mike.gif
Mike Visits 1 - 3: Cardiovascular risk assessment and management of a male diabetic patient with multivessel CAD and low HDL-CCardiologyPeter P. Toth, MD, PhD, FNLA27-Dec-121 AMA
1 ACPE
1 ANCC
1 CDR
26-Dec-13mike
icon_.png
Non-CETP Novel Targets and New Drug Therapies Targeting HDLCardiologyMichael H. Davidson, MD, FNLA *18-Dec-121 AMA
1 ACPE
1 ANCC
1 CDR
18-Dec-13267540
icon-raj.gif
Raj
Raj Visit 1 - 50-year-old overweight man with dyslipidemiaCardiologyHarold E. Bays, MD18-Sep-090.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
17-Sep-10raj
Raj Visit 2 - 50-year-old overweight man with dyslipidemiaCardiologyHarold E. Bays, MD12-Oct-090.5 AMA
0.5 ACPE
0.5 ANCC
0.5 CDR
11-Oct-10raj
NLAicon.jpg
Reducing CVD Risk in the Patient with High Triglycerides and Metabolic Syndrome or DM-2CardiologySee Faculty section below for a complete list of faculty.06-Aug-121 AMA
0.8 ACPE
0.8 ANCC
1 CDR
05-Aug-13244970
icon_rosa.gif
Rosa
Rosa Visit 1: A 51-year-old woman with CAD not at lipid goalsCardiologyJames A. Underberg, MD, MS, FACPM, FACP, FNLA04-Oct-120.5 AMA
0.5 ACPE
0.5 ANCC
03-Oct-13rosa
Rosa Visits 2 - 3: A 51-year-old woman requiring additional lipid-lowering therapyCardiologyJames A. Underberg, MD, MS, FACPM, FACP, FNLA04-Oct-120.5 AMA
0.5 ACPE
0.5 ANCC
03-Oct-13rosa
icon_suparna.gif
Suparna Visits 1 - 2: Cardiovascular Disease Risk Assessment and Management of a Woman with Metabolic SyndromeCardiologyBenjamin J. Ansell, MD, FNLA19-Dec-121 AMA
1 ACPE
1 ANCC
1 CDR
18-Dec-13suparna
CETPicon.jpeg
THE EMERGENT SCIENCE OF HDL AND ITS METABOLISM: Mechanistic Understanding of CETP Antagonism and BeyondCardiologyPeter P. Toth, MD, PhD, FNLA*01-Oct-121 AMA
1 ACPE
1 ANCC
1 CDR
30-Sep-13248326